You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
多瑞醫藥(301075.SZ):左氧氟沙星氯化鈉注射液獲藥品註冊證書
格隆匯 07-08 17:15

格隆匯7月8日丨多瑞醫藥(301075.SZ)公佈,公司全資子公司湖北多瑞藥業有限公司近日收到國家藥品監督管理局核准簽發的關於左氧氟沙星氯化鈉注射液的《藥品註冊證書》。

左氧氟沙星氯化鈉注射液的適應症:適用於敏感細菌所致的下列感染:慢性支氣管炎急性細菌性感染、社區獲得性肺炎(包括由衣原體、支原體弓|起的社區獲得性肺炎)和醫院獲得性肺炎、急性上額竇炎、急性單純性下尿路感染、複雜性尿路感染、急性腎盂腎炎、複雜性和非複雜性皮膚及軟組織感染等由敏感細菌引起的感染。

根據米內網中國城市公立醫院化學藥終端競爭格局數據顯示,左氧氟沙星氯化鈉注射液2021-2023年年銷售額依次為65,778萬元、83,831萬元、113,185萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account